1. HBW Insight

EU Regulatory Round-Up: RWE Platform Proposed, Brexit Transition Update, EPI Principles Published

 
• By David Ridley

The latest EU regulatory developments - EMA and HMA are looking to build an EU-wide real-world data platform; EU OTC firms can operate as normal in the UK until the end of the year; EMA, HMA and the EC have published key principles on how to develop and use electronic product information for medicines marketed within the EU.  

3d render of Europe map Earth globe
• Source: Shutterstock

The European Medicines Agency – in partnership with the Heads of Medicines Agencies (HMA) – is one step closer to establishing a regulatory framework and platform for harnessing real-world data (RWD) and real-world evidence (RWD).

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation